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PICOT Statement

Background Information

Outcomes

Population – Patients admitted for substance use disorder treatments
from injection drug use (IDU) with positive Hepatitis C
Intervention – The states must prevent opioid misuse and addiction,
reduce overdose deaths and other harmful consequences, improve
opioid addiction treatment, and improve addiction care in the criminal
justice system.
Comparison – Patients who report positive Hepatitis C without
abusing opioids through IDU
Outcome – Reducing HCV infections by ending the opioid epidemic
Time – Now!! Prevent and help people who abuse opioids through IDU
(injection drug use)

• Drug overdose is now the leading cause of death in the United
States among people under age 50. Opioid related death rates
keep rising over the U.S. and in nearly almost every state.
• A significant portion of opioid related addiction, overdose, and
death is now related to the use of heroin and deadly synthetic
opioids like fentanyl and carfentanil, which are not bjeing
prescribed by physicians nor monitored through PDMPs. Rather,
these illicit drugs often are cheaper and more accessible than
prescription opioids and the more potent and deadly versions of
them are increasingly mixed into heroin, cocaine, and other drugs,
most of the time without the knowledge or awareness of those
who use them.
• Approximately 15.7 percent of total state spending goes toward
substance use and addiction; 94 percent of that amount is spent
on addressing the consequences of substance use and addiction
rather than on prevention, treatment, or research.
The opioid epidemic is a stark
reminder of the consequences of a
societal problem that was not
brought into attention for years.
Most of the reason the problem
was never addressed was because
of the stigma associated with drug
use and the reluctance to confront
it as a public health problem.

• Theoretical models suggest that combining HCV treatment with
risk-reduction measures is the most effective way to prevent
transmission among injection-drug users.
• An effective vaccine could reduce the risk of HCV transmission if
it were routinely provided to people before the onset of highrisk behaviors.
• To make significant and meaningful progress in ending the
opioid crisis, the states need to assume the role of adopting a
public health approach to the opioid crisis, and to addiction
more generally. States can build on the momentum at the
federal level to implement a public health approach to the
problem, using the funds that have been made available to them
through recent landmark pieces of legislation.

Abstract
Hepatitis C (HCV) is rapidly growing and has become the most common
blood-borne infection throughout the United States. The objective of
this study was to compare trends in rates of injection drug use (IDU),
specifically opioid injection, with national trends in the incidence of
acute HCV infection to assess whether these events correlated over
time. The methodology was a literature review. To test for trends
researchers calculated the annual incidence rate, demographics, and
risk characteristics of reported cases of acute HCV infection using
surveillance data from 2004 to 2014. They also analyzed the annual
percentage of admissions to substance use disorder treatment facilities
reporting injection drug use for the same time period by type of drug
injected and demographic characteristics. Using the six sources, the
results showed that significant increases in opioid injection mirrored
those for reported cases of acute HCV infection among demographic
subgroups. Injection drug use was the primary risk factor for HCV
transmission and the leading cause of incidence in the U.S.
Interventions were identified to help end the “opioid epidemic”, which
then in return would reduce positive cases of HCV infections.

Interventions
• More awareness from the states of the opioid epidemic and risks that
come with it.
• Integrated health services that include syringe service programs,
medication-assisted treatment, and comprehensive HCV testing and
linkage to care and treatment of HCV-infected PWID are essential to
reduce prevalence and incidence among the population.
• Population based screening of young adults may be a reasonable
strategy for identifying infected people and connecting them to
treatment, as has been done among baby boomers.
• Development of new virologic-detection assays, available as point-ofcare tests, will improve detection of new infections while simplifying
clinical monitoring.
• Effective HCV vaccine
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From 2013 on, the number of HCVrelated deaths in the U.S. has
exceeded the number of deaths
associated with HIV and 59 other
infectious diseases combined.
Hepatitis C is rapidly growing
throughout the U.S. and is the most
common blood-borne infection
now. Injection drug use (IDU) is the
primary risk factor for HCV
transmission and is the leading
cause of incidence in the United Summary of Studies
Significant increases in opioid
States.
injection mirrored those for
reported cases of acute HCV
infection among demographic
subgroups.

Gaps in the Literature
• Underreporting of cases of acute HCV infection is common.
• The case definition for acute infection only describes people with
signs and symptoms of illness, yet most acute HCV infections are
asymptomatic.
• The TEDS (Treatment Episode Data Set) data that was used has
limitations because treatment is provided to only a fraction of
persons with SUD in the United States. It is likely that there is a
larger number of persons with SUD who inject drugs than what is
reported. The TEDS analysis also could have counted the same
person for multiple readmissions. Reporting varies in each state
to TEDS, so the state-specific trends and state-by-state
comparisons should be interpreted with caution.
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